Skip to main content
. 2016 Dec 30;19:46–49. doi: 10.1016/j.gore.2016.12.010

Table 1.

Primary treatment (n = 89).

Primary treatment N (%)
Surgery: 74 (83.1%)
 Wide local excision 55 (61.8%)
 Radical vulvectomy 13 (14.6%)
 Skinning vulvectomy 4 (4.5%)
 Mohs surgery 2 (2.3%)
Topical therapy: 5 (5.6%)
 Imiquimod 4 (4.5%)
 5-Fluorouracil 1 (1.1%)
Laser ablation 1 (1.1%)
Unknown 9 (10.1%)